Transitioning from local production to global innovation requires Chinese companies to actively engage with international regulators and payers to build essential cross-border confidence, Marwan Fathallah, CEO of the Drug Information Association, told Yicai at the 2026 DIA China Annual Meeting in Shanghai. The future of the industry lies in a two-way exchange of innovation, he noted, adding that scientific success must be paired with strong, credible global partnerships.